SEC Info - Harmony Biosciences Holdings, Inc., et al. - ‘SC 13D’ on 8/24/23 re: Zynerba Pharmaceuticals, Inc.

SEC Info℠

Home

Help

Please Sign In

Harmony Biosciences Holdings, Inc., et al. – ‘SC 13D’ on 8/24/23 re: Zynerba Pharmaceuticals, Inc.

On: Thursday, 8/24/23, at 5:23pm ET · Accession #: 1140361-23-41175 · File #: 5-88971

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/24/23  Harmony Biosciences Holdings, Inc SC 13D                 2:113K Zynerba Pharmaceuticals, Inc.     Broadridge Fin’l So… Inc
          Xylophone Acquisition Corp.

Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      Statement of Acquisition of Beneficial Ownership    HTML    106K 
                by an "Active" Investor                                          
 2: EX-99.3     Miscellaneous Exhibit                               HTML      8K

Filing Submission 0001140361-23-041175 – SGML Text

Original SGML Text submitted by:	Broadridge Financial Solutions, Inc. (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Harmony Biosciences Holdings, Inc., et al. – ‘SC 13D’ on 8/24/23 re: Zynerba Pharmaceuticals, Inc.

On: Thursday, 8/24/23, at 5:23pm ET · Accession #: 1140361-23-41175 · File #: 5-88971

Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68Filing Table of Contents

To view the SGML, please refresh this page.

Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D — WA’68

Filing Table of Contents

To view the SGML, please refresh
this page.